• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconDrugs

Drugs

Page 28 of 30
Ross William Ulbricht
TechThe Silk Road mastermind appealed his life sentence
By Chris MatthewsJune 5, 2015
Silk Road mastermind pleads for light sentence
RetailSilk Road mastermind pleads for light sentence
By Benjamin SnyderMay 27, 2015
Biopharma deals are booming this year with no end in sight
FinanceBiopharma deals are booming this year with no end in sight
By Laura LorenzettiMay 8, 2015
J&J brings in ethicists to judge on requests for experimental drugs
FeaturesJ&J brings in ethicists to judge on requests for experimental drugs
By ReutersMay 7, 2015
Inside of a Gilead Sciences Lab
TechDrugmaker Alexion boosts its rare drug pipeline with $8.4 billion deal
By ReutersMay 6, 2015
PA: Mylan Headquarters
FinanceMylan goes big with $29 billion offer to buy Perrigo
By Laura LorenzettiApril 8, 2015
States ask U.S. Congress to launch inquiry of herbal supplements
RetailStates ask U.S. Congress to launch inquiry of herbal supplements
By ReutersApril 2, 2015
IL: Corporations In Illinois
FeaturesTakeda’s ready to shell out $2.2 billion to settle Actos drug cases
By Laura LorenzettiApril 1, 2015
Where do CEOs with addictions go when they hit bottom?
LeadershipWhere do CEOs with addictions go when they hit bottom?
By Daniel BukszpanMarch 25, 2015
Merck
FeaturesMerck halts study in light of melanoma drug’s success
By Laura LorenzettiMarch 24, 2015
George Scangos, CEO of Biogen Inc. speaks during Reuters Health Summit in New York
FeaturesHow Biogen scored the most successful Alzheimer’s drug so far
By Jen WiecznerMarch 20, 2015
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., waits for the start of their annual general meeting in Laval, Quebec
FinanceValeant comes out a winner after upping its Salix bid to $11.1 billion
By Laura LorenzettiMarch 16, 2015
Logo of Swiss drugmaker Novartis is seen at its headquarters in Basel
FeaturesFDA approves the first biosimilar for the U.S. market
By Laura LorenzettiMarch 6, 2015
IL: Corporations In Illinois
FinanceAbbVie to buy cancer drug maker Pharmacyclics in $21 billion deal
By ReutersMarch 4, 2015
Inside Rite Aid Ahead of Earnings Reports
RetailRite Aid takes aim at CVS with a $2 billion purchase
By Laura LorenzettiFebruary 11, 2015
1...
  • 26
  • 27
  • 28
  • 29
  • 30
30
Most Popular
Real Estate
Gen Z fled San Francisco for Texas and Florida. Now they’re turning ‘welcomer cities’ into the next big tech townsplaceholder alt text
By Fortune EditorsApril 2, 2026
Innovation
Google CEO Sundar Pichai says we’re just a decade away from a new normal of extraterrestrial data centersplaceholder alt text
By Fortune EditorsApril 3, 2026
Magazine
The Walmart billionaires next door: Quiet backlash is brewing against the heirs who remade the retailer’s hometownplaceholder alt text
By Fortune EditorsApril 3, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.